# A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients

> **NCT04101383** · NA · COMPLETED · sponsor: **Geropharm** · enrollment: 42 (actual)

## Conditions studied

- Clamp Study

## Interventions

- **DRUG:** RinGlar®
- **DRUG:** Lantus®

## Key facts

- **NCT ID:** NCT04101383
- **Lead sponsor:** Geropharm
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-16
- **Primary completion:** 2018-02-16
- **Final completion:** 2018-02-16
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04101383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04101383, "A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04101383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*